MAPK9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.489800E-01
Normal-vs-Stage2
6.850400E-01
Normal-vs-Stage3
2.961100E-03
Normal-vs-Stage4
9.039000E-01
Stage1-vs-Stage2
3.717800E-01
Stage1-vs-Stage3
7.582200E-03
Stage1-vs-Stage4
7.164200E-01
Stage2-vs-Stage3
8.368000E-02
Stage2-vs-Stage4
7.948600E-01
Stage3-vs-Stage4
2.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.465000E-01
Normal-vs-AfricanAmerican
4.452200E-01
Normal-vs-Asian
5.568000E-01
Caucasian-vs-AfricanAmerican
6.654800E-01
Caucasian-vs-Asian
8.062400E-01
AfricanAmerican-vs-Asian
9.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.932600E-01
Normal-vs-Female
7.002200E-01
Male-vs-Female
7.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.413550E-01
Normal-vs-Age(41-60Yrs)
7.566800E-01
Normal-vs-Age(61-80Yrs)
5.457600E-01
Normal-vs-Age(81-100Yrs)
3.840200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.093800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.709600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.465600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.524270E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.536000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.640600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.282400E-01
Normal-vs-Daily Drinker
7.267400E-01
Normal-vs-Weekly Drinker
6.435200E-01
Normal-vs-Occasional Drinker
8.783800E-01
Normal-vs-Social Drinker
9.538600E-01
Non Drinker-vs-Daily Drinker
6.533600E-01
Non Drinker-vs-Weekly Drinker
8.834800E-01
Non Drinker-vs-Occasional Drinker
3.665600E-01
Non Drinker-vs-Social Drinker
2.865000E-01
Daily Drinker-vs-Weekly Drinker
8.289000E-01
Daily Drinker-vs-Occasional Drinker
6.861800E-01
Daily Drinker-vs-Social Drinker
5.753000E-01
Weekly Drinker-vs-Occasional Drinker
5.631400E-01
Weekly Drinker-vs-Social Drinker
4.701600E-01
Occasional Drinker-vs-Social Drinker
8.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.661200E-01
Normal-vs-Grade 2
8.332200E-01
Normal-vs-Grade 3
8.247200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.091400E-01
Grade 1-vs-Grade 3
9.948400E-01
Grade 1-vs-Grade 4
5.661200E-01
Grade 2-vs-Grade 3
8.481000E-01
Grade 2-vs-Grade 4
8.332200E-01
Grade 3-vs-Grade 4
8.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.965800E-01
Normal-vs-NonDiabetic
7.708400E-01
Diabetic-vs-NonDiabetic
2.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.344400E-01
Normal-vs-NoPancreatitis
6.369200E-01
Pancreatitis-vs-NoPancreatitis
2.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.458400E-01
Normal-vs-N1
6.403800E-01
N0-vs-N1
2.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.450400E-01
Normal-vs-TP53-NonMutant
8.508000E-01
TP53-Mutant-vs-TP53-NonMutant
9.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
